| CAI | 8-K | neutral | 2/10 | Caris Life Sciences filed an 8-K to announce that management will use an investor presentation at the Morgan Stanley 24t | Sep 14, 2026 |
| ASB | 8-K | neutral | 3/10 | Associated Banc-Corp filed an 8-K furnishing an investor presentation that reaffirms all FY2026 guidance metrics (total | Sep 14, 2026 |
| PLAY | 8-K | bearish | 7/10 | Dave & Buster's Q2 2026 revenue fell 2.4% YoY to $544.1M, missing consensus of $556.8M, and the company swung to a GAAP | Sep 14, 2026 |
| UPXI | 8-K | bullish | 6/10 | Upexi amended its existing credit facility with BitGo Prime, reducing the interest rate from 11.5% to 7.5% per annum and | Sep 14, 2026 |
| BKV | 8-K | mixed | 6/10 | BKV Corp issued $575M of 1.625% convertible senior notes due 2031, used ~$64.7M of proceeds to enter into capped call tr | Sep 14, 2026 |
| ZSQR | 8-K | mixed | 6/10 | Z Squared Inc. closed its acquisition of Paradox Data LLC, issuing 5,000 shares of Series A Convertible Preferred Stock | Sep 14, 2026 |
| VWAV | 8-K | bearish | 7/10 | VisionWave Holdings issued a $5M convertible debenture to YA II PN, Ltd. as the second closing under a July 2026 SPA, bu | Sep 14, 2026 |
| OMEX | 8-K | bearish | 5/10 | Odyssey Marine Exploration amended its existing Note Purchase Agreement with American Ocean Minerals Corporation (AOM) t | Sep 14, 2026 |
| GCTK | 8-K | bearish | 6/10 | Glucotrack shareholders approved two Nasdaq-required proposals at a September 11, 2026 special meeting: (1) full issuanc | Sep 14, 2026 |
| AIM | 8-K | bearish | 7/10 | AIM ImmunoTech converted approximately $400,000 of its existing promissory note with Streeterville Capital into 1,749,43 | Sep 14, 2026 |
| AMT | 8-K | neutral | 4/10 | American Tower completed a $1.6B registered public offering of senior unsecured notes across three tranches (5.300% 2031 | Sep 14, 2026 |
| CHGA | 8-K | bearish | 7/10 | Change Agents Corporation (CHGA) raised $250,000 in gross proceeds via a private placement of OID promissory notes (aggr | Sep 14, 2026 |
| SAFX | 8-K | bullish | 7/10 | XCF Global entered Amendment No. 1 to its Business Combination Agreement with DevvStream and Southern Energy, which dele | Sep 14, 2026 |
| RAKR | 8-K | bearish | 6/10 | Rainmaker Worldwide terminated its long-standing consulting agreements with Larchwood Management Partners and 2752128 On | Sep 14, 2026 |
| TMQ | 8-K | bearish | 6/10 | Trilogy Metals Inc. (TMQ) filed an 8-K covering multiple items: entry into a material agreement (Item 1.01), unregistere | Sep 14, 2026 |
| SWRD | 8-K | bearish | 7/10 | No summary provided | Sep 14, 2026 |
| CLDT | 8-K | neutral | 3/10 | Chatham Lodging Trust appointed William P. (Liam) Brown, the recently retired Group President of Marriott International | Sep 14, 2026 |
| CW | 8-K | neutral | 4/10 | Curtiss-Wright's Board authorized an additional $510 million for share repurchases, raising total authorization to $700 | Sep 14, 2026 |
| CR | 8-K | neutral | 2/10 | Crane Co. filed an 8-K solely to furnish a Regulation FD disclosure (Item 7.01) with an accompanying exhibit (Item 9.01) | Sep 14, 2026 |
| ALLR | 8-K | neutral | 2/10 | Allarity Therapeutics filed an 8-K with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), but | Sep 14, 2026 |
| NWSA | 8-K | neutral | 3/10 | Analysis based on filing metadata only, document content was unavailable. This is an 8-K with Items 8.01 (Other Events) | Sep 14, 2026 |
| ONCO | 8-K | bearish | 6/10 | Onconetix (ONCO) entered into a Grid Promissory Note to lend Realbotix LLC up to $5.0 million, with an initial $2.5 mill | Sep 14, 2026 |
| ONCO | DEFA14A, 8-K | neutral | 4/10 | Onconetix (ONCO) entered into a Grid Promissory Note to lend Realbotix LLC up to $5.0 million, with an initial $2.5 mill | Sep 14, 2026 |
| ONDS | 8-K | bullish | 8/10 | Ondas Inc. acquired 100% of Gate Technologies (Israel) and Bron Technologies (Poland) on September 14, 2026, for $105M c | Sep 14, 2026 |
| TGL | 8-K | neutral | 4/10 | Treasure Global Inc (TGL) entered into a $2,000,000 software development agreement with Mestiz Technology Sdn Bhd to bui | Sep 14, 2026 |
| NRXP | 8-K | neutral | 2/10 | NRX Pharmaceuticals filed an 8-K furnishing an investor presentation used in meetings with investors and analysts on Sep | Sep 14, 2026 |
| MSTR | 8-K | neutral | 3/10 | Strategy Inc filed an 8-K reporting no ATM or bitcoin activity for the week ending September 13, 2026, while repurchasin | Sep 14, 2026 |
| TELO | 8-K | neutral | 4/10 | Telomir Pharmaceuticals announced preclinical in-vitro data from Ohio State University showing Telomir-Zn inhibits cell | Sep 14, 2026 |
| SRRK | 8-K | bullish | 8/10 | Scholar Rock announced FDA approval of ISEMBYLD (apitegromab-mstn) for spinal muscular atrophy (SMA) in patients aged 2+ | Sep 14, 2026 |
| ANY | 8-K | neutral | 4/10 | Sphere 3D Corp. (ANY) filed an 8-K furnishing an investor presentation outlining its strategy to convert its 50 MW of op | Sep 14, 2026 |